VLGC Virologic (MM)

ViroLogic to Present at Pacific Growth Equities 2005 Life Sciences Growth Conference SO. SAN FRANCISCO, Calif., May 31 /PRNewswire-FirstCall/ -- ViroLogic, Inc. (NASDAQ:VLGC) announced today that William D. Young, CEO and Chairman of ViroLogic, is scheduled to present a corporate overview at the Pacific Growth Equities 2005 Life Sciences Growth Conference at 4:30 p.m. on Monday, June 6th at the Mark Hopkins Inter-Continental Hotel in San Francisco, CA. To access the live audio broadcast, or the subsequent archived recording, log on to the investor relations section of the Company's website at http://www.virologic.com/. The archived version of the webcast will be available on the Company's website for one month. About ViroLogic ViroLogic is a biotechnology company advancing individualized medicine by discovering, developing and marketing innovative products to guide and improve treatment of serious infectious diseases and cancer. The Company's products are designed to help doctors optimize treatment regimens for their patients that lead to better outcomes and reduced costs. The Company's technology is also being used by numerous biopharmaceutical companies to develop new and improved antiviral therapeutics and vaccines as well as targeted cancer therapeutics. More information about the Company and its technology can be found on its web site at http://www.virologic.com/. DATASOURCE: ViroLogic, Inc. CONTACT: Alfred Merriweather, Vice President and CFO of ViroLogic, +1-650-635-1100; or Carolyn Bumgardner Wang of WeissComm Partners, +1-415-946-1065 or , for ViroLogic Web site: http://www.virologic.com/

Copyright